These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8181220)

  • 1. [Incidence and type of dyslipidemia in a diabetic population].
    Urbani A; Repeti M; Barbaro D; Bassano G; Bernini F; Boldrin M; Crestini AM; Lombardo M; Marino O
    Clin Ter; 1994 Mar; 144(3):237-40. PubMed ID: 8181220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes and dyslipidemia].
    Fatati G
    Recenti Prog Med; 1999 Jan; 90(1):21-4. PubMed ID: 10193161
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic dyslipidemia.
    Chahil TJ; Ginsberg HN
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):491-510, vii-viii. PubMed ID: 16959582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dyslipidemia of diabetes and insulin resistance].
    Halimi S
    Nephrologie; 2000; 21(7):345-6. PubMed ID: 11200607
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting dyslipidemia--the key to CHD risk reduction in the diabetic population?
    Betteridge DJ; Rosenson RS
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S1-2. PubMed ID: 15953502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
    Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
    Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The cardiovascular risk score and its application in the DAI study].
    Grassi G; Monge L
    Ann Ist Super Sanita; 2003; 39(2):139-44. PubMed ID: 14587211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus: a study utilizing the revised diagnostic criteria.
    de Andino RM; Mendoza M; Vera M; Martínez V
    Bol Asoc Med P R; 1988 Feb; 80(2):48-50. PubMed ID: 3348881
    [No Abstract]   [Full Text] [Related]  

  • 10. Should you put all diabetic patients on statins?
    Leiter LA
    J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary risk and dyslipidemia in type 2 diabetic patients.
    Udawat H; Goyal RK; Maheshwari S
    J Assoc Physicians India; 2001 Oct; 49():970-3. PubMed ID: 11848328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations for treating dyslipidemia in special diabetic populations.
    Harmel AP
    Diabetes Metab Res Rev; 2002; 18(2):88-95. PubMed ID: 11994899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD; Banga JD; Erkelens DW
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macroangiopathic complications in type 2 diabetic patients seen at an Italian diabetes center].
    Maggini M; Spila Alegiani S; Raschetti R
    Ann Ist Super Sanita; 2003; 39(2):165-71. PubMed ID: 14587214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidemia in diabetes. A comprehensive analysis.
    Larsen JL
    Adv Nurse Pract; 1998 Apr; 6(4):36-43. PubMed ID: 9611482
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of oral anti-diabetic agents in modifying cardiovascular risk factors.
    Shin JJ; Rothman J; Farag A; McFarlane SI; Sowers JR
    Minerva Med; 2003 Dec; 94(6):401-8. PubMed ID: 14976468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aggressive control of cardiovascular risk factors].
    Abrignani MG; Sclavo M
    Ital Heart J; 2004 Apr; 5 Suppl 4():25S-32S. PubMed ID: 15185475
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenesis and significance of diabetic dyslipidemia].
    Zeman M; Zák A
    Cas Lek Cesk; 2004; 143(5):302-6. PubMed ID: 15305764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
    Larrañaga I; Arteagoitia JM; Rodriguez JL; Gonzalez F; Esnaola S; Piniés JA;
    Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.